Table 1.
Patient demographic data
| Control | AMI | |
|---|---|---|
| n | 12 | 15 |
| STEMI | n/a | 12 (80.0%) |
| M:F | 6:6 | 9:6 |
| Age (mean, SD) | 57.3 ± 18.4 | 65.5 ± 11.9 |
| CV risk | ||
| Diabetes mellitus | 4 (33.3%) | 5 (33.3%) |
| Hypertension | 8 (66.7%) | 10 (66.7%) |
| Dyslipidemia | 6 (50.0%) | 14 (93.3%) |
| Smoker | 3 (25.0%) | 5 (33.3%) |
| Previous coronary artery disease | 0 | 3 (20.0%) |
| Admission medication | ||
| Aspirin | 5 (41.7%) | 14 (93.3%) |
| Ticagrelor/clopidogrel/prasugrel | 0 | 12 (80.0%) |
| Oral anticoagulants | 1 (8.3%) | 1 (6.67%) |
| ACEI | 7 (58.3%) | 13 (86.7%) |
| β‐blocker | 8 (66.7%) | 12 (80.0%) |
| Spironolactone | 0 | 2 (13.33%) |
| Statin | 8 (66.7%) | 15 (100.0%) |
STEMI, ST‐segment elevation myocardial infarction; n, number; M, male; F, female; CV, cardiovascular; ACEI, angiotensin converting enzyme inhibitor.